| Dr Orest John Kozicky, MD | |
|
1088 North Broadway, Yonkers, NY 10701 | |
| (914) 207-0004 | |
| (914) 965-0107 |
| Full Name | Dr Orest John Kozicky |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 43 Years |
| Location | 1088 North Broadway, Yonkers, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861496481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 151151 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St John's Riverside Hospital | Yonkers, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sjr Medical, Pc | 5991608440 | 32 |
News Archive
...and may largely reward those with higher performance at baseline, according to a study in the October 12 issue of JAMA: The Journal of the American Medical Association.
Glaucoma, the second leading cause of blindness, usually stems from elevated eye pressure, which in turn damages and destroys specialized neurons in the eye known as retinal ganglion cells. To better understand these cellular changes and how they influence the progression and severity of glaucoma, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute turned to a mouse model of the disease.
Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
› Verified 8 days ago
| Entity Name | Sjr Medical, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366468936 PECOS PAC ID: 5991608440 Enrollment ID: O20040130000847 |
News Archive
...and may largely reward those with higher performance at baseline, according to a study in the October 12 issue of JAMA: The Journal of the American Medical Association.
Glaucoma, the second leading cause of blindness, usually stems from elevated eye pressure, which in turn damages and destroys specialized neurons in the eye known as retinal ganglion cells. To better understand these cellular changes and how they influence the progression and severity of glaucoma, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute turned to a mouse model of the disease.
Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
› Verified 8 days ago
| Entity Name | Westchester Digestive Disease Group, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396920872 PECOS PAC ID: 4981610490 Enrollment ID: O20060221000555 |
News Archive
...and may largely reward those with higher performance at baseline, according to a study in the October 12 issue of JAMA: The Journal of the American Medical Association.
Glaucoma, the second leading cause of blindness, usually stems from elevated eye pressure, which in turn damages and destroys specialized neurons in the eye known as retinal ganglion cells. To better understand these cellular changes and how they influence the progression and severity of glaucoma, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute turned to a mouse model of the disease.
Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Orest John Kozicky, MD P.o. Box 998, Attn: Sjr Medical, Pc., Yonkers, NY 10703-0998 Ph: (914) 966-9787 | Dr Orest John Kozicky, MD 1088 North Broadway, Yonkers, NY 10701 Ph: (914) 207-0004 |
News Archive
...and may largely reward those with higher performance at baseline, according to a study in the October 12 issue of JAMA: The Journal of the American Medical Association.
Glaucoma, the second leading cause of blindness, usually stems from elevated eye pressure, which in turn damages and destroys specialized neurons in the eye known as retinal ganglion cells. To better understand these cellular changes and how they influence the progression and severity of glaucoma, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute turned to a mouse model of the disease.
Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
› Verified 8 days ago
Dr. Lawrence Fayez Neshiwat, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 944 N Broadway, Suite 205, Yonkers, NY 10701 Phone: 914-237-1941 Fax: 914-237-1950 | |
Dr. Andrew E Lan, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 1010 Central Park Ave, Yonkers, NY 10704 Phone: 914-964-4000 Fax: 914-964-4044 | |
Dr. Rajendra M Rampersaud, MD Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 970 North Broadway Suite 209, Rajendra M Rampersaud Md, Yonkers, NY 10701 Phone: 914-965-3366 Fax: 914-965-1310 | |
Dr. Ronald B Dennett, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 73 Market St, Yonkers, NY 10710 Phone: 914-848-8085 Fax: 914-607-4771 | |
Sang H Kim, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1086 N Broadway Ste 240, Yonkers, NY 10701 Phone: 914-377-0300 Fax: 914-327-2183 | |
Atul M Limaye, M.D Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1010 N Broadway, Yonkers, NY 10701 Phone: 914-968-5515 | |
Jose Matos, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 31 Beechwood Ter, Yonkers, NY 10705 Phone: 914-309-0429 |